Craig E. Wheelock
Impact in
- Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology
- Health, Toxicology and Mutagenesis top 0.5%
- Environmental Toxicology and Ecotoxicology
Papers in
-
- Metabolomics and Mass Spectrometry Studies 43
- Sphingolipid Metabolism and Signaling 13
- Physiology 48
- Asthma and respiratory diseases 35
- Co-authors
- Bruce D. Hammock (34 shared papers)Åsa M. Wheelock (21 shared papers)Antonio Checa (38 shared papers)Romanas Chaleckis (17 shared papers)Jesper Z. Haeggström (20 shared papers)Isabel Meister (10 shared papers)Pei Zhang (10 shared papers)Guomin Shan (2 shared papers)
- Journals
- Analytical Chemistry (10 papers)European Respiratory Journal (9 papers)Scientific Reports (6 papers)Journal of Allergy and Clinical Immunology (6 papers)Bioorganic & Medicinal Chemistry (5 papers)
- Partner nations
- SwedenUnited StatesJapan
In The Last Decade
Craig E. Wheelock
228 papers receiving 8.4k citations
Peers
Comparison fields: 5 of 175
- Biochemistry 960
- Health, Toxicology and Mutagenesis 1.2k
- Immunology 1.2k
- Biological Psychiatry 132
- Physiology 1.4k
Countries citing papers authored by Craig E. Wheelock
This map shows the geographic impact of Craig E. Wheelock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig E. Wheelock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig E. Wheelock more than expected).
Fields of papers citing papers by Craig E. Wheelock
This network shows the impact of papers produced by Craig E. Wheelock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig E. Wheelock. The network helps show where Craig E. Wheelock may publish in the future.
Co-authors
The 25 scholars most cited alongside Craig E. Wheelock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 272 | |
| 2 | 2018 | 262 | |
| 3 | 2018 | 224 | |
| 4 | 2005 | 224 | |
| 5 | 2010 | 201 | |
| 6 | 2008 | 191 | |
| 7 | 2004 | 185 | |
| 8 | 2019 | 173 | |
| 9 | 2002 | 168 | |
| 10 | 2013 | 157 | |
| 11 | 2020 | 134 | |
| 12 | 2017 | 130 | |
| 13 | 2005 | 125 | |
| 14 | 2017 | 115 | |
| 15 | 2018 | 110 | |
| 16 | 2019 | 107 | |
| 17 | 2017 | 103 | |
| 18 | 2017 | 100 | |
| 19 | 2021 | 96 | |
| 20 | 2015 | 94 |
About Craig E. Wheelock
Craig E. Wheelock is a scholar working on Molecular Biology, Physiology, Biochemistry, Pulmonary and Respiratory Medicine and Pharmacology, having authored 232 papers that have together received 8.5k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (43 papers), Asthma and respiratory diseases (35 papers), Eicosanoids and Hypertension Pharmacology (34 papers), Fatty Acid Research and Health (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Environmental Toxicology and Ecotoxicology (15 papers), Computational Drug Discovery Methods (15 papers) and Sphingolipid Metabolism and Signaling (13 papers). The work is most often cited by research in Biochemistry (960 citations), Health, Toxicology and Mutagenesis (1.2k citations), Immunology (1.2k citations), Biological Psychiatry (132 citations) and Physiology (1.4k citations). Craig E. Wheelock has collaborated with scholars based in Sweden, United States and Japan. Frequent co-authors include Bruce D. Hammock, Åsa M. Wheelock, Antonio Checa, Romanas Chaleckis, Jesper Z. Haeggström, Isabel Meister, Pei Zhang, Guomin Shan, Sven‐Erik Dahlén and James A. Ottea. Their work appears in journals such as Analytical Chemistry, European Respiratory Journal, Scientific Reports, Journal of Allergy and Clinical Immunology and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.